| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6885507b2b76e0dfa5c17c71a8043fcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate |
2004-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f8c83febf21ee0f862c8cdc0c9b4f3 |
| publicationDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005013969-A1 |
| titleOfInvention |
Antipsychotic agent with socializing properties |
| abstract |
This invention concerns the use of the combination of a predominant 5HT2c antagonist and a D2 antagonist for use as an antipsychotic with socializing properties. The invention more specifically concerns the use of a compound of formula (I), its pharmaceutically acceptable salts, more preferably the tartrate and mandelate salts for the preparation of a medicament with socializing properties for the treatment of schizophrenia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10770072-B2 |
| priorityDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |